In the highly regulated field of orthopedic surgery, Moventra Medical Technology provides more than just manufacturing; we provide strategic partnership. Our 18,600 m² facility is engineered for compliance, housing state-of-the-art CNC precision systems that guarantee the structural integrity required for ankle arthroplasty and fixation devices. By leveraging China’s robust medical supply chain, we offer competitive scalability without compromising on the rigorous quality standards required by FDA and CE audits.
We understand that navigating global regulatory landscapes (MDR, FDA 510(k)) is critical. Moventra implements a comprehensive quality management system, including 48 dedicated QC inspectors and 100% pre-shipment inspection. Our technical documentation support ensures our partners achieve market entry faster, with full traceability from raw material to final surgical implementation.
The global ankle replacement market is shifting toward patient-specific instrumentation (PSI) and minimally invasive techniques. Moventra is at the forefront of this shift, investing in R&D for biocompatible titanium alloy implants and specialized PEEK materials. Our focus is on increasing "Information Gain" by providing clinical-grade data to surgeons, facilitating better outcomes in complex foot and ankle trauma cases.
Q: What makes your ankle implants suitable for high-end international markets?
A: Our implants undergo rigorous mechanical performance testing, surface finish analysis, and sterility verification, meeting international ASTM and ISO standards for class III medical devices.
Q: Can you handle custom design requests (OEM/ODM)?
A: Yes, with 86 R&D engineers, we specialize in drawing-based and sample-based manufacturing, from rapid prototyping to full-scale clinical supply.
Moventra Medical
